North America’s Most Awarded Drug Substance Manufacturer
24 Life Science Leader CMO awards from 2014-2017
Click and view our video series on How to Select a CMO.
COMPANY OVERVIEW
PCI is one of the most awarded cGMP API manufacturing companies that offers you everything you need from initial process research to commercial API manufacturing. We have more than 20 years of experience in chemical manufacturing, which has enabled us to develop deep expertise in custom NCEs, controlled substances (Schedule II-V), generic APIs, and custom manufactured fine chemicals. PCI combines the responsiveness of a small company with the capacity and capabilities of a much larger one.
IN THE NEWS
August 18, 2018
The Art Reducing API Failures
August 10, 2018
Growth of targeted therapies gives rise to need for flexible manufacturing of smaller API quantities
July 13, 2018
This CDMO Deal Significant Sign Of The Times
June 12, 2018
Top Mistakes in Analytical Method Validation and How to Avoid Them
August 6, 2018
How Micronization Yields Soluble, Bioavailable API Particles
July 30, 2018
An Ounce of Prevention Ensures Reliable Utility Systems in Drug Manufacturing
July 20, 2018
Growth of targeted therapies gives rise to need for flexible manufacturing of smaller API quantities
July 9, 2018
Providing Incentives to Attract Life Science Leaders to the State is Half the Battle
July 2, 2018
Ensuring Smooth Sailing When It Comes to FDA Inspections
June 28, 2018
Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.
UPCOMING EVENTS
Click on an event below to arrange a meeting with PCI
